PATENT CLAIM ANALYSIS

Application Number: 15745588
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "215000"]

Abstract:
Pharmaceutical compounds, compositions, and methods are presented in which various heterocyclic thiosemicarbazone derivatives are prepared. Contemplated compounds will be suitable to inhibit or reduce cellular growth or proliferation and are thus beneficial in the manufacture of drugs to treat neoplastic diseases.

Claim (Index 25):
The pharmaceutical composition of  claim 24 , wherein the compound is present in an amount effective to reduce cell growth or proliferation of a cancer cell when administered to a mammal in need thereof.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 86.0
- Lexical Diversity: 1.25
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14297526', '10850429', '14592628', '13809836', '13552460']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7519238757667258
- 35 USC 102 Novelty (BERT): 0.504754895738883
- Combined Prediction Score: 0.7272069777639415
- Mean Citation Score: 217.944202
- Max Citation Score: 222.50946
- Similarity Product: 139.87398266136643

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test